HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Codex Review Of Infant Formula Pathogen Contamination Sought By U.S.

This article was originally published in The Tan Sheet

Executive Summary

The U.S. is requesting that the Codex Committee on Nutrition & Foods for Special Dietary Uses (CCNFSDU) address concerns related to the presence of pathogens in infant formula

You may also be interested in...



Infant Formula E. Sakazakii Requirement In Final Rule Unnecessary, IFC Says

FDA should not create a microbiological testing requirement for E. sakazakii in infant formula, the International Formula Council states in Aug. 26 comments on the agency's proposed infant formula GMPs and quality control procedures

Codex Health Claims Guides Development Renewed By Nutrition Committee

The Codex Alimentarius Committee on Nutrition & Foods for Special Dietary Uses (CCNFSDU) is planning to initiate "new work" on the elaboration of proposed draft recommendations on the scientific basis for health claims, according to a recently-released Codex report

Powdered formula contamination

Methods to validate that milk-based powdered infant formulas do not contain the pathogen Enterobacter sakazakii posted on 1CFSAN Web site. Directions, required equipment and materials, media and reagents are referenced in guidelines. In late March, Mead Johnson announced recall of Portagen powdered formula due to possible contamination (2"The Tan Sheet" April 15, 2002, In Brief)...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS131015

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel